{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:58:13Z","timestamp":1791561493747,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T00:00:00Z","timestamp":1738972800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biotechnology Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.btre.2025.e00882","type":"journal-article","created":{"date-parts":[[2025,2,9]],"date-time":"2025-02-09T01:53:58Z","timestamp":1739066038000},"page":"e00882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Quality by design for transient RBD-Fc fusion protein production in Chinese hamster ovary cells"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-6834-5334","authenticated-orcid":false,"given":"Araya","family":"Jivapetthai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanatchaporn","family":"Arunmanee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3833-0537","authenticated-orcid":false,"given":"Natapol","family":"Pornputtapong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.btre.2025.e00882_bib0001","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1016\/j.vaccine.2020.06.066","article-title":"Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates","volume":"38","author":"Ren","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.btre.2025.e00882_bib0002","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.btre.2025.e00882_bib0003","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41586-020-2665-2","article-title":"Structures and distributions of SARS-CoV-2 spike proteins on intact virions","volume":"588","author":"Ke","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.btre.2025.e00882_bib0004","article-title":"The SARS-CoV-2 receptor-binding domain elicits a potent neutralizing response without antibody-dependent enhancement","author":"Quinlan","year":"2020","journal-title":"SSRN Electron. J. Immunity"},{"key":"10.1016\/j.btre.2025.e00882_bib0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-020-00402-5","article-title":"RBD-fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.btre.2025.e00882_bib0006","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1021\/acsomega.0c03512","article-title":"Characterization of the SARS-CoV-2 S protein: biophysical, biochemical, structural, and antigenic analysis","volume":"6","author":"Herrera","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.btre.2025.e00882_bib0007","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.btre.2025.e00882_bib0008","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.btre.2025.e00882_bib0009","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.btre.2025.e00882_bib0010","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.btre.2025.e00882_bib0011","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.btre.2025.e00882_bib0012","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.btre.2025.e00882_bib0013","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/s41564-020-0695-z","article-title":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses, the species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2","volume":"5","year":"2020","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.btre.2025.e00882_bib0014","doi-asserted-by":"crossref","first-page":"7205","DOI":"10.1016\/j.vaccine.2020.09.058","article-title":"Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain fc fusion protein in mice","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.btre.2025.e00882_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2024.100444","article-title":"Development of an RBD-Fc fusion vaccine for COVID-19","volume":"16","author":"Sun","year":"2024","journal-title":"Vaccine X"},{"key":"10.1016\/j.btre.2025.e00882_bib0016","doi-asserted-by":"crossref","DOI":"10.1556\/1886.2024.00045","article-title":"Preclinical assessment of a recombinant RBD-Fc fusion protein as SARS-CoV-2 candidate vaccine","author":"Dashti","year":"2024","journal-title":"Eur. J. Microbiol. Immunol. (Bp)"},{"key":"10.1016\/j.btre.2025.e00882_bib0017","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41423-021-00658-z","article-title":"Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice","volume":"18","author":"Sun","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.btre.2025.e00882_bib0018","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4155\/pbp.13.6","article-title":"Quality by design for biopharmaceuticals: a historical review and guide for implementation","volume":"1","author":"Elliott","year":"2013","journal-title":"Pharm. Bioprocess"},{"key":"10.1016\/j.btre.2025.e00882_bib0019","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.vaccine.2014.02.028","article-title":"Implementation of QbD for the development of a vaccine candidate","volume":"32","author":"Haas","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.btre.2025.e00882_bib0020","first-page":"223","article-title":"A comprehensive review on quality by design (QbD) in pharmaceuticals","volume":"21","author":"Patel","year":"2013","journal-title":"Int. J. Pharm. Sci. Rev. Res."},{"key":"10.1016\/j.btre.2025.e00882_bib0021","first-page":"1","article-title":"Application of quality by design in the current drug development","volume":"12","author":"Zhang","year":"2017","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.btre.2025.e00882_bib0022","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.btre.2025.e00882_bib0023","unstructured":"ICH, Q8(R2) Pharmaceutical Development, 2009."},{"key":"10.1016\/j.btre.2025.e00882_bib0024","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejpb.2021.06.004","article-title":"Design of experiments and design space approaches in the pharmaceutical bioprocess optimization","volume":"166","author":"Kasemiire","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.btre.2025.e00882_bib0025","article-title":"Overview of protein expression by mammalian cells","volume":"5","author":"Gray","year":"2001","journal-title":"Curr. Protoc. Protein Sci. Chapter"},{"key":"10.1016\/j.btre.2025.e00882_bib0026","doi-asserted-by":"crossref","first-page":"443","DOI":"10.4155\/pbp.15.25","article-title":"Optimizing Chinese hamster ovary cell line development via targeted control of N-glycosylation","volume":"3","author":"Alves","year":"2015","journal-title":"Pharm. Bioprocess"},{"key":"10.1016\/j.btre.2025.e00882_bib0027","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6972-2_1","article-title":"Heterologous protein production in CHO cells","author":"Alves","year":"2017"},{"key":"10.1016\/j.btre.2025.e00882_bib0028","first-page":"123","article-title":"Product quality considerations for mammalian cell culture process development and manufacturing","volume":"139","author":"Gramer","year":"2014","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"10.1016\/j.btre.2025.e00882_bib0029","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1002\/cpps.77","article-title":"Optimization of protein expression in mammalian cells","volume":"95","author":"Hunter","year":"2019","journal-title":"Curr. Protoc. Protein Sci."},{"key":"10.1016\/j.btre.2025.e00882_bib0030","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jbiotec.2016.04.028","article-title":"Comparative study of polyethylenimines for transient gene expression in mammalian HEK293 and CHO cells","volume":"227","author":"Delafosse","year":"2016","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.btre.2025.e00882_bib0031","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/B978-0-12-418687-3.00018-5","article-title":"Transient mammalian cell transfection with polyethylenimine (PEI)","author":"Longo","year":"2013","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.btre.2025.e00882_bib0032","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejpb.2012.02.018","article-title":"Application of quality by design to the characterization of the cell culture process of an Fc-fusion protein","volume":"81","author":"Rouiller","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.btre.2025.e00882_bib0033","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pep.2017.03.018","article-title":"A high density CHO-S transient transfection system: comparison of ExpiCHO and Expi293","volume":"134","author":"Jain","year":"2017","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.btre.2025.e00882_bib0034","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.xphs.2019.02.004","article-title":"Quality by design-driven process development of cell culture in bioreactor for the production of foot-and-mouth veterinary vaccine","volume":"108","author":"Li","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.btre.2025.e00882_bib0035","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1002\/jps.23744","article-title":"Application of a quality by design approach to the cell culture process of monoclonal antibody production, resulting in the establishment of a design space","volume":"102","author":"Nagashima","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.btre.2025.e00882_bib0036","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0288486","article-title":"CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2","volume":"18","author":"Laotee","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.btre.2025.e00882_bib0037","unstructured":"United States Pharmacopeia, USP COVID-19 vaccine quality assessment toolkits, 2021."},{"key":"10.1016\/j.btre.2025.e00882_bib0038","unstructured":"World Health Organization, WHO target product profiles for COVID-19 vaccines, 2020."},{"key":"10.1016\/j.btre.2025.e00882_bib0039","series-title":"ICH Guideline Q9 On Quality Risk Management (EMA\/CHMP\/ICH\/24235\/2006)","year":"2015"},{"key":"10.1016\/j.btre.2025.e00882_bib0040","series-title":"Achieving High Titers Using CHO Cells To Express Proteins in a Single Medium For Growth and Transient Transfection in Batch Culture","first-page":"4","author":"Johnson","year":"2013"},{"key":"10.1016\/j.btre.2025.e00882_bib0041","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12575-017-0060-7","article-title":"Efficient and inexpensive transient expression of multispecific multivalent antibodies in Expi293 cells","volume":"19","author":"Fang","year":"2017","journal-title":"Biol. Proced Online"},{"key":"10.1016\/j.btre.2025.e00882_bib0042","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.procbio.2013.07.002","article-title":"Effects of the dilution rate on cell cycle distribution and PEI-mediated transient gene expression by CHO cells in continuous culture","volume":"48","author":"Li","year":"2013","journal-title":"Process Biochem."},{"key":"10.1016\/j.btre.2025.e00882_bib0043","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbiotec.2018.06.307","article-title":"Optimization of a high-cell-density polyethylenimine transfection method for rapid protein production in CHO-EBNA1 cells","volume":"281","author":"Stuible","year":"2018","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.btre.2025.e00882_bib0044","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jbiotec.2005.09.010","article-title":"Adaptation of Chinese hamster ovary cells to low culture temperature: cell growth and recombinant protein production","volume":"122","author":"Yoon","year":"2006","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.btre.2025.e00882_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.pep.2022.106071","article-title":"Expression, purification and characterization of SARS-CoV-2 spike RBD in ExpiCHO cells","volume":"194","author":"De March","year":"2022","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.btre.2025.e00882_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fpls.2023.1202570","article-title":"Plant-produced RBD and cocktail-based vaccine candidates are highly effective against SARS-CoV-2, independently of its emerging variants","volume":"14","author":"Mamedov","year":"2023","journal-title":"Front. Plant Sci."},{"key":"10.1016\/j.btre.2025.e00882_bib0047","first-page":"1","article-title":"Large-scale purification and characterization of recombinant receptor-binding domain (RBD) of SARS-CoV-2 spike protein expressed in yeast","volume":"11","author":"Nagar","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.btre.2025.e00882_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.01860","article-title":"Engineering of Fc fragments with optimized physicochemical properties implying improvement of clinical potentials for fc-based therapeutics","volume":"8","author":"Yang","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Biotechnology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X25000098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2215017X25000098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:45:41Z","timestamp":1791560741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2215017X25000098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":48,"alternative-id":["S2215017X25000098"],"URL":"https:\/\/doi.org\/10.1016\/j.btre.2025.e00882","relation":{},"ISSN":["2215-017X"],"issn-type":[{"value":"2215-017X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quality by design for transient RBD-Fc fusion protein production in Chinese hamster ovary cells","name":"articletitle","label":"Article Title"},{"value":"Biotechnology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.btre.2025.e00882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"e00882"}}